KLAC
59
2
XOM
60
4
XRAY
26
4
GIS
37
3
JWN
49
4
GM
65
7
KMI
61
4
LB
56
11
ICE
55
2
PWR
67
2
CAG
34
7
TEL
60
2
LEN
53
-3
PRU
70
8
ORCL
65
2
MTB
55
7
DNB
48
-2
MS
74
5
ADBE
49
3
DVA
72
4
KLAC
59
2
XOM
60
4
XRAY
26
4
GIS
37
3
JWN
49
4
GM
65
7
KMI
61
4
LB
56
11
ICE
55
2
PWR
67
2
CAG
34
7
TEL
60
2
LEN
53
-3
PRU
70
8
ORCL
65
2
MTB
55
7
DNB
48
-2
MS
74
5
ADBE
49
3
DVA
72
4
Financhill
Back

GT Biopharma Vs. Simulations Plus Industry Stock Comparison

Sell
49

GTBP
GT Biopharma

Last Price:
2.03
Seasonality Move:
-3.67%
Sell
30

SLP
Simulations Plus

Last Price:
30.22
Seasonality Move:
4.76%
Sell
49
GT Biopharma (GTBP) is a Sell

Is GT Biopharma a Buy, Sell or Hold?

  • The current GT Biopharma [GTBP] share price is $2.02. The Score for GTBP is 49, which is 2% below its historic median score of 50, and infers higher risk than normal.
  • GTBP is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
30
Simulations Plus (SLP) is a Sell

Is Simulations Plus a Buy, Sell or Hold?

  • The current Simulations Plus [SLP] share price is $30.22. The Score for SLP is 30, which is 40% below its historic median score of 50, and infers higher risk than normal.
  • SLP is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

GTBP Stock Price Chart

What is GT Biopharma's stock price today?

  • The GT Biopharma share price today is $2.02
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and GTBP is experiencing slight selling pressure.

SLP Stock Price Chart

What is Simulations Plus's stock price today?

  • The Simulations Plus share price today is $30.22
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SLP is experiencing selling pressure, which indicates risk of future bearish movement.

GTBP Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.03 Sell
Relative Strength Index (14 RSI): 42.95 Sell
Chaikin Money Flow: -11804 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (2.03 - 2.19) Sell
Bollinger Bands (100): (1.93 - 3.53) Sell

SLP Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -1.31 Sell
Relative Strength Index (14 RSI): 30.89 Sell
Chaikin Money Flow: -69284 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (30.76 - 33.9) Sell
Bollinger Bands (100): (33.91 - 46.71) Sell

GTBP Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 2.13 Sell
20-day SMA: 2.12 Sell
50-day SMA: 2.22 Sell
200-day SMA: 3.86 Sell
8-day EMA: 2.11 Sell
20-day EMA: 2.13 Sell
50-day EMA: 2.29 Sell
200-day EMA: 4.74 Sell

SLP Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 30.96 Sell
20-day SMA: 31.69 Sell
50-day SMA: 34.89 Sell
200-day SMA: 41.59 Sell
8-day EMA: 30.92 Sell
20-day EMA: 31.96 Sell
50-day EMA: 34.8 Sell
200-day EMA: 40.17 Sell

GT Biopharma Earnings Growth & GTBP Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.43 per share, and a decrease next year of $0.00 per share.

Simulations Plus Earnings Growth & SLP Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.14 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.09 per share, and an increase next year of $0.08 per share.

GT Biopharma Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Simulations Plus Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):